Immunocore - BIO Deutschland
Immunocore - BIO Deutschland
Immunocore - BIO Deutschland
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Overall summary<br />
●<br />
●<br />
●<br />
<strong>Immunocore</strong> has a pipeline of mTCRs targeting multiple cancers<br />
High affinity mTCRs can overcome antigen down-regulation in<br />
vitro and in vivo<br />
The anti-CD3 effector function can<br />
• Redirect T cell killing at extremely low concentrations<br />
• Prevent tumour formation over extended periods in vivo<br />
● Gp100 development candidate being progressed to clinic in 2010<br />
●<br />
<strong>Immunocore</strong> seeking partners across the pipeline<br />
<strong>Immunocore</strong>
Change language